For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.
EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that's why most skin care maker use EGF to care our skin.
And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.
Scope of the Report:
This report focuses on the Epidermal Growth Factor (EGF) (CAS 62253-63-8) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Epidermal Growth Factor (EGF) includes liquid and powder. The proportion of liquid in 2016 is about 25%, the proportion of powder in 2016 is about 75%.
The application of Epidermal Growth Factor (EGF) is divided into EGF Cream, EGF Lotion, EGF Mask and others. The most of Epidermal Growth Factor (EGF) is EGF Cream, and the market share of that is about 45% in 2016.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 34% in 2016. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 25% in 2016. And South America in the third largest consumption region with the consumption market share of 10%.
Market competition is intense. Pavay, Radiant, BIO-FD&C, LipoTrue, BIOEFFECT are the leaders of the industry, with high-end customers in the industry.
The worldwide market for Epidermal Growth Factor (EGF) (CAS 62253-63-8) is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 140 million US$ in 2023, from 110 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- EGF Cream
- EGF Lotion
- EGF Mask
There are 15 Chapters to deeply display the global Epidermal Growth Factor (EGF) (CAS 62253-63-8) market.
Chapter 1, to describe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Epidermal Growth Factor (EGF) (CAS 62253-63-8), with sales, revenue, and price of Epidermal Growth Factor (EGF) (CAS 62253-63-8), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Epidermal Growth Factor (EGF) (CAS 62253-63-8), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Epidermal Growth Factor (EGF) (CAS 62253-63-8) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Epidermal Growth Factor (EGF) (CAS 62253-63-8) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source